GO:1905367 positive regulation of intralumenal vesicle formation: Multivesicular Body Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905367 describes any process that activates or increases the frequency, rate or extent of intralumenal vesicle formation, the inward budding of the endosomal limiting membrane that generates multivesicular bodies (MVBs).
• The ESCRT machinery, including Tsg101, Alix and ESCRT-III subunits such as CeVPS-32, is a central positive regulator of intralumenal vesicle budding in vitro and in cells [2,7,8].
• Accessory proteins such as SCAMP3, the Arf GTPase-activating proteins ADAP1 and ARAP1, and the ubiquitin ligase Rsp5 modulate cargo selection and MVB biogenesis [3,4,5].
• NRBF2, a component of the PI3K-III complex, supports autophagic and endosomal membrane trafficking relevant to intralumenal vesicle formation.
• LRRK2 and glucocerebrosidase activity influence extracellular vesicle release of bis(monoacylglycerol)phosphate, linking MVB biology to Parkinson disease and lysosomal storage disorders.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of positive regulators of intralumenal vesicle formation in disease-relevant cell types.
Description
GO:1905367, positive regulation of intralumenal vesicle formation, is a Gene Ontology biological process term that captures any activity that activates or increases the frequency, rate or extent of intralumenal vesicle formation. Intralumenal vesicles (ILVs) are formed by inward budding of the endosomal limiting membrane, producing multivesicular bodies (MVBs) that sort cargo for degradation or release [2,7]. This process is fundamental to receptor downregulation, extracellular vesicle biogenesis and cellular quality control, and its dysregulation is linked to neurodegeneration and lysosomal disease [1,6]. Mechanistically, positive regulation of intralumenal vesicle formation is executed by the endosomal sorting complex required for transport (ESCRT) machinery together with accessory factors that recruit cargo and deform membranes [2,7,8]. In vitro budding assays demonstrated that Alix and Tsg101 are required for ILV formation into late endosomes, establishing them as positive regulators. Additional regulators such as SCAMP3, ADAP1, ARAP1 and Rsp5 fine-tune cargo incorporation and membrane budding [3,4,5]. For researchers, GO:1905367 provides a precise annotation target when studying MVB biogenesis, extracellular vesicle cargo, and endolysosomal dysfunction in disease [1,3,6]. Understanding which genes positively regulate ILV formation, and how, is essential for interpreting CRISPR screens, proteomic cargo analyses and imaging-based MVB assays.
positive regulation of intralumenal vesicle formation At A Glance
| GO ID | GO:1905367 |
|---|---|
| GO term | positive regulation of intralumenal vesicle formation |
| Ontology | biological_process |
| Synonym | activation of endosome membrane budding; upregulation of intralumenal vesicle formation; positive regulation of endosome membrane budding |
| Major function | Increases the frequency, rate or extent of inward budding of the endosomal membrane to form intralumenal vesicles |
| Related machinery | ESCRT complexes (Tsg101, Alix, ESCRT-III), SCAMP3, Arf GTPase-activating proteins, Rsp5 [2,3,4,5,7,8] |
| Cellular context | Late endosome / multivesicular body biogenesis and cargo sorting [2,7] |
| Disease relevance | Neurodegeneration, lysosomal storage disorders and extracellular vesicle-mediated pathology [1,6] |
What Is GO:1905367?
In our own words, GO:1905367 refers to any biological process that activates or increases the frequency, rate or extent of intralumenal vesicle formation, the inward budding event at endosomal membranes that creates vesicles inside the endosome lumen. It is a positive regulatory node upstream of multivesicular body maturation and cargo sorting [2,7].
Why Is positive regulation of intralumenal vesicle formation Important in Cell Biology?
Positive regulation of intralumenal vesicle formation is important because it controls the sorting of membrane proteins and lipids into MVBs, thereby determining whether cargo is degraded in lysosomes or released as extracellular vesicles [2,7]. This regulatory step influences receptor signaling, neuronal proteostasis and intercellular communication, and its perturbation has been linked to Parkinson disease and lysosomal storage disorders through LRRK2 and glucocerebrosidase. Consequently, genes annotated to GO:1905367 are high-value candidates for mechanistic studies and therapeutic targeting.
• Controls multivesicular body biogenesis and endosomal cargo sorting [2,7].
• Determines extracellular vesicle cargo and release, affecting intercellular communication.
• Regulates degradation of signaling receptors and contributes to signal attenuation.
• Supports autophagic and endolysosomal degradation pathways via NRBF2 and PI3K-III complexes.
• Links to Parkinson disease through LRRK2 and glucocerebrosidase-dependent EV release.
• Relevant to Alzheimer disease models through NRBF2-mediated APP-CTF degradation.
• Provides mechanistic entry points for lysosomal storage disorder research.
• Enables CRISPR-based functional dissection of ESCRT and accessory factors [2,3,4,5,7,8].
• Informs biomarker and therapeutic strategies targeting EV biogenesis.
• Supports annotation and interpretation of genome-wide screens for endosomal trafficking [4,5].
What Happens During positive regulation of intralumenal vesicle formation?
Initiation at the endosomal limiting membrane
In simple terms: The process starts when proteins on the endosome surface begin to pull the membrane inward.
Positive regulation of intralumenal vesicle formation begins at the late endosomal limiting membrane, where ESCRT components and accessory factors assemble to initiate inward budding [2,7]. Ultrastructural analysis of ESCRT proteins revealed endosome-associated tubular-vesicular membranes that support this budding function. In vitro budding assays showed that Alix and Tsg101 are required for efficient ILV formation into late endosomes, defining them as positive regulators.
Cargo recognition and sorting
In simple terms: Specific cargo proteins are recognized and tagged so they end up inside the forming vesicles.
Cargo recognition is a prerequisite for productive ILV formation, and multiple sorting determinants within cargo such as Sna3 depend on the ubiquitin ligase Rsp5. SCAMP3 regulates the MVB pathway, influencing how cargo is incorporated into intralumenal vesicles. Arf GTPase-activating proteins ADAP1 and ARAP1 regulate incorporation of CD63 into multivesicular bodies, demonstrating that cargo-specific regulation is part of positive regulation of ILV formation.
Membrane deformation and ESCRT-III function
In simple terms: The membrane is bent inward by a molecular machine that pinches off a small vesicle.
Membrane deformation and scission are driven by ESCRT-III polymerization, and the ESCRT-III protein CeVPS-32 is enriched in domains distinct from CeVPS-27 and CeVPS-23 at the endosomal membrane of epithelial cells. This spatial organization supports the constriction and release of intralumenal vesicles, a core positive regulatory step in MVB biogenesis [7,8].
Coordination with autophagic and lipid pathways
In simple terms: Other cellular recycling and lipid-handling systems help the vesicle-forming machinery work properly.
NRBF2 is involved in the autophagic degradation process of APP-CTFs in Alzheimer disease models, linking autophagic machinery to endosomal membrane trafficking relevant to ILV formation. LRRK2 and glucocerebrosidase activity regulate extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate, connecting lipid metabolism to MVB and ILV biology.
Key Genes Involved in GO:1905367 positive regulation of intralumenal vesicle formation
The following genes and proteins have been experimentally implicated in positive regulation of intralumenal vesicle formation or closely related MVB biogenesis steps.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Tsg101 | ESCRT-I component required for ILV budding in vitro | Core positive regulator; knockout reduces ILV formation |
| Alix | ESCRT-associated protein required for ILV budding | Mechanistic studies of MVB biogenesis |
| SCAMP3 | Regulates the MVB pathway and cargo sorting | Modulates ILV cargo incorporation |
| ADAP1 | Arf GTPase-activating protein regulating CD63 incorporation into MVBs | Cargo-specific regulation of ILV formation |
| ARAP1 | Arf GTPase-activating protein regulating CD63 incorporation into MVBs | Cargo-specific regulation of ILV formation |
| Rsp5 | Ubiquitin ligase required for Sna3 sorting determinants | Ubiquitin-dependent cargo sorting into ILVs |
| NRBF2 | PI3K-III complex component involved in autophagic degradation of APP-CTFs | Links autophagy and endosomal trafficking in Alzheimer models |
| CeVPS-32 | ESCRT-III protein enriched in endosomal membrane domains | ESCRT-III spatial organization during ILV formation |
| CeVPS-27 | ESCRT-III protein with distinct endosomal domains | Comparative ESCRT-III localization studies |
| CeVPS-23 | ESCRT-III protein with distinct endosomal domains | Comparative ESCRT-III localization studies |
| LRRK2 | Regulates extracellular vesicle release of bis(monoacylglycerol)phosphate | Parkinson disease-related MVB/EV biology |
| GBA (glucocerebrosidase) | Activity regulates EV-mediated BMP release | Lysosomal storage disorder and Parkinson disease models |
| CD63 | Tetraspanin cargo incorporated into MVBs via ADAP1/ARAP1 | Readout for ILV cargo sorting |
| Sna3 | Cargo with multiple MVB sorting determinants | Model cargo for ubiquitin-dependent sorting |
| APP | Cargo whose CTFs are degraded via NRBF2-dependent autophagy | Alzheimer disease-related endosomal trafficking |
How Is positive regulation of intralumenal vesicle formation Regulated?
Positive regulation of intralumenal vesicle formation is controlled by the coordinated action of ESCRT complexes, accessory proteins and lipid-modifying enzymes [2,7,8]. Alix and Tsg101 are required for in vitro ILV budding, and their activity defines a minimal positive regulatory module. SCAMP3 modulates the MVB pathway, while ADAP1 and ARAP1 regulate cargo-specific incorporation of CD63, indicating that regulation occurs at both general and cargo-selective levels [3,4]. Ubiquitination via Rsp5 provides an additional layer of cargo selection. NRBF2 links autophagic machinery to endosomal degradation of APP-CTFs, and LRRK2 together with glucocerebrosidase activity regulates EV-mediated release of bis(monoacylglycerol)phosphate, connecting disease-associated kinases and lysosomal enzymes to ILV-related pathways [1,6].
positive regulation of intralumenal vesicle formation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LRRK2 | Parkinson disease; EV release of bis(monoacylglycerol)phosphate | Knockout or point-mutation iPSC-derived neurons |
| GBA | Lysosomal storage disorder; Parkinson disease risk | Knockout or overexpression in neuronal cell lines |
| NRBF2 | Alzheimer disease; APP-CTF autophagic degradation | Knockout in neuroblastoma or iPSC-derived neurons |
| CD63 | EV cargo sorting; cancer biomarker biology | Knock-in tagged CD63 for imaging |
| Tsg101 | MVB biogenesis; endosomal sorting | Knockout with ILV budding rescue assays |
Parkinson disease and lysosomal dysfunction
LRRK2 and glucocerebrosidase activity regulate extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate, implicating positive regulation of intralumenal vesicle formation and MVB biology in Parkinson disease and lysosomal storage disorders. Dysregulation of this pathway may alter EV cargo and contribute to neuronal dysfunction.
Alzheimer disease and autophagic-lysosomal degradation
NRBF2 is involved in the autophagic degradation of APP-CTFs in Alzheimer disease models, linking positive regulation of endosomal membrane trafficking to amyloid precursor protein processing. Impaired ILV formation may contribute to APP-CTF accumulation and neurodegeneration.
Cancer and extracellular vesicle signaling
Because intralumenal vesicle formation determines EV cargo, its positive regulators can influence intercellular communication in tumors [1,4]. Cargo-specific regulators such as ADAP1 and ARAP1 control CD63 incorporation into MVBs, a tetraspanin widely used as an EV marker.
From positive regulation of intralumenal vesicle formation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for ILV formation? | CRISPR knockout in HeLa or HEK293 cells followed by in vitro budding assay |
| Does a disease mutation alter ILV cargo sorting? | Point-mutation knock-in of LRRK2 or GBA variants |
| Where does a regulator localize during ILV formation? | Tagged knock-in of ESCRT-III or SCAMP3 with fluorescent tag [3,8] |
| Does overexpression increase MVB number or EV release? | Doxycycline-inducible overexpression of Alix, Tsg101 or NRBF2 [2,6] |
| Which cargo requires a specific adaptor? | Knockout of ADAP1 or ARAP1 with CD63 incorporation readout |
| Does ubiquitination control cargo sorting? | Knockout or point mutation of Rsp5 with Sna3 cargo assay |
How to Study the positive regulation of intralumenal vesicle formation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro ILV budding assay | Formation of intralumenal vesicles into late endosomes | Testing Alix and Tsg101 requirement |
| Electron microscopy | Ultrastructure of endosome-associated tubular-vesicular membranes | Localizing ESCRT function |
| Fluorescence imaging | Endosomal domain enrichment of ESCRT-III proteins | Comparing CeVPS-32, CeVPS-27 and CeVPS-23 |
| CD63 incorporation assay | Cargo sorting into MVBs | Evaluating ADAP1 and ARAP1 function |
| EV BMP release assay | Extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate | LRRK2 and glucocerebrosidase studies |
| Cargo sorting determinant mapping | Ubiquitin-dependent sorting of Sna3 | Rsp5 ligase studies |
| Autophagic degradation assay | APP-CTF turnover | NRBF2 function in Alzheimer models |
| SCAMP3 perturbation | MVB pathway regulation | Cargo trafficking studies |
In vitro ILV budding assays
In vitro budding of intralumenal vesicles into late endosomes can be reconstituted and quantified, and this assay established Alix and Tsg101 as positive regulators. It remains a gold-standard method for testing whether a gene product directly increases ILV formation.
Imaging of MVB and ESCRT organization
Ultrastructural analysis and fluorescence imaging reveal endosome-associated tubular-vesicular membranes and distinct ESCRT-III domains, as shown for CeVPS-32, CeVPS-27 and CeVPS-23 [7,8]. These methods localize positive regulators at the site of ILV budding [7,8].
Cargo incorporation and EV release assays
CD63 incorporation into MVBs and EV-mediated release of bis(monoacylglycerol)phosphate can be measured to assess cargo-specific regulation by ADAP1, ARAP1, LRRK2 and glucocerebrosidase [1,4]. Such assays connect molecular regulators to extracellular vesicle output [1,4].
Genetic and proteomic dissection of MVB sorting
Characterization of sorting determinants within cargo such as Sna3, combined with ubiquitin ligase perturbation, defines how Rsp5-dependent ubiquitination contributes to ILV cargo selection. NRBF2 studies further link autophagic degradation of APP-CTFs to endosomal trafficking.
How CRISPR Can Be Used to Study GO:1905367 positive regulation of intralumenal vesicle formation
Knockout
CRISPR knockout of Tsg101, Alix or ESCRT-III components can abolish or reduce intralumenal vesicle formation, providing causal evidence for positive regulation [2,8]. Knockout of SCAMP3, ADAP1 or ARAP1 enables dissection of cargo-specific contributions to MVB biogenesis [3,4].
Point Mutation
Point-mutation knock-in of disease-associated variants such as LRRK2 or GBA allows testing whether specific residues alter EV-mediated release of bis(monoacylglycerol)phosphate and ILV-related trafficking. Point mutations in cargo sorting determinants can also be modeled to study Rsp5-dependent ubiquitination.
Knock-in
Tagged knock-in of ESCRT-III proteins, SCAMP3 or CD63 supports live imaging of endosomal domains and cargo incorporation during ILV formation [3,4,8]. Knock-in of fluorescent reporters enables quantitative tracking of MVB dynamics.
Overexpression
Overexpression of positive regulators such as Alix, Tsg101 or NRBF2 can increase ILV formation or autophagic degradation readouts, complementing loss-of-function studies [2,6]. Overexpression models are useful for testing sufficiency of a candidate regulator in MVB biogenesis [2,6].
How EDITGENE Supports positive regulation of intralumenal vesicle formation Research
Researchers studying positive regulation of intralumenal vesicle formation-related genes often need to determine whether a candidate gene is causally involved in ILV budding, cargo sorting or extracellular vesicle release, and CRISPR-based models provide the most direct route to that answer [2,4,6].
Contact EDITGENE today to design your custom CRISPR model for positive regulation of intralumenal vesicle formation research.
Frequently Asked Questions About positive regulation of intralumenal vesicle formation
What is GO:1905367 positive regulation of intralumenal vesicle formation?
GO:1905367 is a Gene Ontology biological process term describing any process that activates or increases the frequency, rate or extent of intralumenal vesicle formation, the inward budding of endosomal membranes that creates multivesicular bodies.
What genes are involved in positive regulation of intralumenal vesicle formation?
Key genes include Tsg101, Alix, SCAMP3, ADAP1, ARAP1, Rsp5, NRBF2, ESCRT-III components such as CeVPS-32, and disease-related LRRK2 and GBA [1,2,3,4,5,6,8].
How is intralumenal vesicle formation regulated?
It is regulated by ESCRT complexes, accessory proteins such as SCAMP3 and Arf GTPase-activating proteins, ubiquitin ligases like Rsp5, and lipid-related enzymes including glucocerebrosidase [1,2,3,4,5].
What is the role of Tsg101 in intralumenal vesicle formation?
Tsg101 is an ESCRT-I component required for in vitro budding of intralumenal vesicles into late endosomes, making it a core positive regulator.
What is the role of Alix in multivesicular body biogenesis?
Alix is required together with Tsg101 for efficient intralumenal vesicle budding in vitro, supporting MVB biogenesis.
How does SCAMP3 regulate the MVB pathway?
SCAMP3 regulates the MVB pathway and influences cargo trafficking into intralumenal vesicles.
What do ADAP1 and ARAP1 do in multivesicular bodies?
ADAP1 and ARAP1 are Arf GTPase-activating proteins that regulate incorporation of CD63 into multivesicular bodies.
Is positive regulation of intralumenal vesicle formation linked to Parkinson disease?
Yes, LRRK2 and glucocerebrosidase activity regulate extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate, connecting this pathway to Parkinson disease and lysosomal disorders.
How does NRBF2 relate to Alzheimer disease and ILV formation?
NRBF2 is involved in autophagic degradation of APP-CTFs in Alzheimer disease models, linking endosomal trafficking to amyloid precursor protein processing.
What methods are used to study positive regulation of intralumenal vesicle formation?
Common methods include in vitro ILV budding assays, electron microscopy, fluorescence imaging of ESCRT-III domains, CD63 incorporation assays and EV release measurements [1,2,4,7,8].
Conclusion
GO:1905367, positive regulation of intralumenal vesicle formation, defines a critical regulatory node in endosomal biology that controls MVB biogenesis, cargo sorting and extracellular vesicle release [2,7]. Experimental evidence from in vitro budding assays, imaging and cargo-specific perturbation studies has established ESCRT components and accessory factors such as Tsg101, Alix, SCAMP3, ADAP1, ARAP1 and Rsp5 as key positive regulators [2,3,4,5,8]. Disease connections through LRRK2, glucocerebrosidase and NRBF2 highlight the biomedical importance of this process in Parkinson disease, lysosomal storage disorders and Alzheimer disease [1,6]. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with library screening and bioinformatics, offer a systematic path to identify and validate new regulators annotated to GO:1905367 [2,4,6]. Such efforts will refine our understanding of MVB biology and may reveal therapeutic targets for diseases driven by endolysosomal dysfunction [1,6].
References
- 1. Meneses-Salas E et al.. 2026. Extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate is regulated by LRRK2 and glucocerebrosidase activity.. Elife 14 PMID: 41925724
- 2. Falguières T et al.. 2008. In vitro budding of intralumenal vesicles into late endosomes is regulated by Alix and Tsg101.. Mol Biol Cell 19(11):4942-55 PMID: 18768755
- 3. Falguières T et al.. 2012. Regulation of the MVB pathway by SCAMP3.. Traffic 13(1):131-42 PMID: 21951651
- 4. Suzuki K et al.. 2024. Arf GTPase-Activating proteins ADAP1 and ARAP1 regulate incorporation of CD63 in multivesicular bodies.. Biol Open 13(5) PMID: 38682696
- 5. Oestreich AJ et al.. 2007. Characterization of multiple multivesicular body sorting determinants within Sna3: a role for the ubiquitin ligase Rsp5.. Mol Biol Cell 18(2):707-20 PMID: 17182849
- 6. Yang C et al.. 2017. NRBF2 is involved in the autophagic degradation process of APP-CTFs in Alzheimer disease models.. Autophagy 13(12):2028-2040 PMID: 28980867
- 7. Welsch S et al.. 2006. Ultrastructural analysis of ESCRT proteins suggests a role for endosome-associated tubular-vesicular membranes in ESCRT function.. Traffic 7(11):1551-66 PMID: 17014699
- 8. Michelet X et al.. 2009. The ESCRT-III protein CeVPS-32 is enriched in domains distinct from CeVPS-27 and CeVPS-23 at the endosomal membrane of epithelial cells.. Biol Cell 101(10):599-615 PMID: 19432559
